Several studies have indicated that there is an abnormal elevation of hepcidin in IPAH patients due to various factors such as BMPR2 mutation and inflammatory response, which can inhibit intestinal iron uptake and intracellular iron export, leading to circulating iron deficiency and intracellular iron overload [12, 27–29]. This evidence concerns the gene HAMP and Iron deficiency anemia.